Literature DB >> 8516321

Nucleic acid binding proteins in highly purified Creutzfeldt-Jakob disease preparations.

T Sklaviadis1, A Akowitz, E E Manuelidis, L Manuelidis.   

Abstract

The nature of the infectious agent causing human Creutzfeldt-Jakob disease (CJD), a slowly progressive dementia, is controversial. As in scrapie, no agent-specific proteins or nucleic acids have been identified. However, biological features of exponential replication and agent strain variation, as well as physical size and density data, are most consistent with a viral structure--i.e., a nucleic acid-protein complex. It is often assumed that nuclease treatment, which does not reduce infectious titer, leaves no nucleic acids of > 50 bp. However, nucleic acids of 500-6000 bp can be extracted from highly purified infectious complexes with a mass of approximately 1.5 x 10(7) daltons. It was therefore germane to search for nucleic acid binding proteins that might protect an agent genome. We here use Northwestern blotting to show that there are low levels of nonhistone nucleic acid binding proteins in highly purified infectious 120S gradient fractions. Several nucleic acid binding proteins were clearly host encoded, whereas others were apparent only in CJD, but not in parallel preparations from uninfected brain. Small amounts of residual host Gp34 (prion protein) did not bind any 32P-labeled nucleic acid probes. Most of the minor "CJD-specific" proteins had an acidic pI, a characteristic of many viral core proteins. Such proteins deserve further study, as they probably contribute to unique properties of resistance described for these agents. It remains to be seen if any of these proteins are agent encoded.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8516321      PMCID: PMC46792          DOI: 10.1073/pnas.90.12.5713

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

1.  RNA-binding proteins of bovine rotavirus.

Authors:  J F Boyle; K V Holmes
Journal:  J Virol       Date:  1986-05       Impact factor: 5.103

2.  Interspecies transmission of Creutzfeldt-Jakob disease to Syrian hamsters with reference to clinical syndromes and strains of agent.

Authors:  E E Manuelidis; E J Gorgacz; L Manuelidis
Journal:  Proc Natl Acad Sci U S A       Date:  1978-07       Impact factor: 11.205

3.  Transmission to animals of Creutzfeldt-Jakob disease from human blood.

Authors:  E E Manuelidis; J H Kim; J R Mericangas; L Manuelidis
Journal:  Lancet       Date:  1985-10-19       Impact factor: 79.321

4.  Specific proteins associated with Creutzfeldt-Jakob disease and scrapie share antigenic and carbohydrate determinants.

Authors:  L Manuelidis; S Valley; E E Manuelidis
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

5.  Extraneural competition between different scrapie agents leading to loss of infectivity.

Authors:  A G Dickinson; H Fraser; I McConnell; G W Outram; D I Sales; D M Taylor
Journal:  Nature       Date:  1975-02-13       Impact factor: 49.962

6.  Nucleotide sequences of the mRNA's encoding the vesicular stomatitis virus G and M proteins determined from cDNA clones containing the complete coding regions.

Authors:  J K Rose; C J Gallione
Journal:  J Virol       Date:  1981-08       Impact factor: 5.103

7.  Sustained viremia in experimental hamster scrapie. Brief report.

Authors:  H Diringer
Journal:  Arch Virol       Date:  1984       Impact factor: 2.574

8.  Viremia in experimental Creutzfeldt-Jakob disease.

Authors:  E E Manuelidis; E J Gorgacs; L Manuelidis
Journal:  Science       Date:  1978-06-02       Impact factor: 47.728

9.  Analysis of Creutzfeldt-Jakob disease infectious fractions by gel permeation chromatography and sedimentation field flow fractionation.

Authors:  T Sklaviadis; R Dreyer; L Manuelidis
Journal:  Virus Res       Date:  1992-12       Impact factor: 3.303

10.  Novel proteinaceous infectious particles cause scrapie.

Authors:  S B Prusiner
Journal:  Science       Date:  1982-04-09       Impact factor: 47.728

View more
  7 in total

1.  Agent-specific Shadoo responses in transmissible encephalopathies.

Authors:  Kohtaro Miyazawa; Laura Manuelidis
Journal:  J Neuroimmune Pharmacol       Date:  2010-01-30       Impact factor: 4.147

2.  Endogenous viral complexes with long RNA cosediment with the agent of Creutzfeldt-Jakob disease.

Authors:  A Akowitz; T Sklaviadis; L Manuelidis
Journal:  Nucleic Acids Res       Date:  1994-03-25       Impact factor: 16.971

3.  Distinct PrP properties suggest the molecular basis of strain variation in transmissible mink encephalopathy.

Authors:  R A Bessen; R F Marsh
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

4.  Replication and spread of CJD, kuru and scrapie agents in vivo and in cell culture.

Authors:  Kohtaro Miyazawa; Kaitlin Emmerling; Laura Manuelidis
Journal:  Virulence       Date:  2011-05-01       Impact factor: 5.882

5.  Quantitative recovery of scrapie agent with minimal protein from highly infectious cultures.

Authors:  Ru Sun; Ying Liu; He Zhang; Laura Manuelidis
Journal:  Viral Immunol       Date:  2008-09       Impact factor: 2.257

6.  Viral particles are required for infection in neurodegenerative Creutzfeldt-Jakob disease.

Authors:  L Manuelidis; T Sklaviadis; A Akowitz; W Fritch
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-23       Impact factor: 11.205

Review 7.  Prions and related neurological diseases.

Authors:  M Pocchiari
Journal:  Mol Aspects Med       Date:  1994
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.